These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17627544)

  • 1. SRC inhibitors and angiogenesis.
    Schenone S; Manetti F; Botta M
    Curr Pharm Des; 2007; 13(21):2118-28. PubMed ID: 17627544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity.
    Pyun BJ; Choi S; Lee Y; Kim TW; Min JK; Kim Y; Kim BD; Kim JH; Kim TY; Kim YM; Kwon YG
    Cancer Res; 2008 Jan; 68(1):227-35. PubMed ID: 18172315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling.
    Donnini S; Monti M; Castagnini C; Solito R; Botta M; Schenone S; Giachetti A; Ziche M
    Int J Cancer; 2007 Mar; 120(5):995-1004. PubMed ID: 17131343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Src in breast cancer.
    Finn RS
    Ann Oncol; 2008 Aug; 19(8):1379-1386. PubMed ID: 18487549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic SRC-kinase domain inhibitors and their structural requirements.
    Schenone S; Manetti F; Botta M
    Anticancer Agents Med Chem; 2007 Nov; 7(6):660-80. PubMed ID: 18045061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors.
    Park SI; Shah AN; Zhang J; Gallick GE
    Expert Opin Ther Targets; 2007 Sep; 11(9):1207-17. PubMed ID: 17845146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastoma.
    Tintori C; Fallacara AL; Radi M; Zamperini C; Dreassi E; Crespan E; Maga G; Schenone S; Musumeci F; Brullo C; Richters A; Gasparrini F; Angelucci A; Festuccia C; Delle Monache S; Rauh D; Botta M
    J Med Chem; 2015 Jan; 58(1):347-61. PubMed ID: 25469771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment.
    Molinari A; Fallacara AL; Di Maria S; Zamperini C; Poggialini F; Musumeci F; Schenone S; Angelucci A; Colapietro A; Crespan E; Kissova M; Maga G; Botta M
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3454-3457. PubMed ID: 30262428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
    Chong YP; Ia KK; Mulhern TD; Cheng HC
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells.
    Munshi N; Groopman JE; Gill PS; Ganju RK
    J Immunol; 2000 Feb; 164(3):1169-74. PubMed ID: 10640727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in targeting SRC in the treatment of breast cancer and other solid malignancies.
    Mayer EL; Krop IE
    Clin Cancer Res; 2010 Jul; 16(14):3526-32. PubMed ID: 20634194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Src in solid tumors.
    Wheeler DL; Iida M; Dunn EF
    Oncologist; 2009 Jul; 14(7):667-78. PubMed ID: 19581523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRC: a century of science brought to the clinic.
    Aleshin A; Finn RS
    Neoplasia; 2010 Aug; 12(8):599-607. PubMed ID: 20689754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
    Hiscox S; Morgan L; Green TP; Barrow D; Gee J; Nicholson RI
    Breast Cancer Res Treat; 2006 Jun; 97(3):263-74. PubMed ID: 16333527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
    Maruyama T; Yamamoto Y; Shimizu A; Masuda H; Sakai N; Sakurai R; Asada H; Yoshimura Y
    Biol Reprod; 2004 Jan; 70(1):214-21. PubMed ID: 14522827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of src tyrosine kinase: the preparation and structure-activity relationship of 4-anilino-3-cyanoquinolines and 4-anilinoquinazolines.
    Wang YD; Miller K; Boschelli DH; Ye F; Wu B; Floyd MB; Powell DW; Wissner A; Weber JM; Boschelli F
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2477-80. PubMed ID: 11078204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src signaling in cancer invasion.
    Guarino M
    J Cell Physiol; 2010 Apr; 223(1):14-26. PubMed ID: 20049846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.